Transcatheter aortic valve-in-valve implantation in degenerative rapid deployment bioprostheses.

Landes, Uri
Dvir, Danny
Schoels, Wolfgang
Tron, Christopher
Ensminger, Stephan
Simonato, Matheus
Schäfer, Ulrich
Bunc, Matjaz
Aldea, Gabriel S
Cerillo, Alfredo
Windecker, Stephan
Marzocchi, Antonio
Andreas, Martin
Amabile, Nicolas
Webb, John
Kornowski, Ran

Open link

Publication date

May 2019

DOI

10.4244/EIJ-D-18-00752

Publisher

Europa Digital & Publishing

Abstract

AIMS The aim of this study was to evaluate transcatheter aortic valve-in-valve (ViV) implantation performance in rapid deployment (ViVr) vs. conventional (ViVc) surgical heart valves. METHODS AND RESULTS A multicentre registry was developed as part of the VIVID international registry. A total of 30 ViVr patients (Perceval, n=24, ATS 3f Enable™, n=5, and the INTUITY, n=1) were evaluated and compared with 2,288 ViVc patients. Propensity score (PS) matching was performed to adjust further for bias. Compared with ViVc, ViVr patients presented twice as early after surgical heart valve (SHV) implantation (55.2±36.1 vs. 118.4±57.7 months, p<0.001), were more commonly female (82.8% vs. 41.3%, p<0.001), and had shorter body stature and redu...